InnovAge (INNV)
(Delayed Data from NSDQ)
$5.50 USD
+0.16 (3.00%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $5.52 +0.02 (0.36%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$5.50 USD
+0.16 (3.00%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $5.52 +0.02 (0.36%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Zacks News
InnovAge Holding Corp. (INNV) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
InnovAge (INNV) delivered earnings and revenue surprises of 50% and 4.85%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
HealthEquity (HQY) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
HealthEquity (HQY) delivered earnings and revenue surprises of 22.86% and 5.43%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
Patterson Cos. (PDCO) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of -25% and 3.59%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
Premier, Inc. (PINC) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Premier (PINC) delivered earnings and revenue surprises of 40.82% and 12.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of -4.17% and 5.13%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
InnovAge Holding Corp. (INNV) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of 0% and 4.07%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -100% and 3.21%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
InnovAge Holding Corp. (INNV) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -200% and 1.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
InnovAge Holding Corp. (INNV) Soars 15.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
InnovAge Holding Corp. (INNV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
HealthEquity (HQY) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
HealthEquity (HQY) delivered earnings and revenue surprises of 12.77% and 1.95%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?
LumiraDx Limited (LMDX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
LumiraDx Limited (LMDX) delivered earnings and revenue surprises of -6.67% and 0.31%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
MDxHealth SA Sponsored ADR (MDXH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
MDxHealth SA Sponsored ADR (MDXH) delivered earnings and revenue surprises of 6.25% and 10.58%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Hold on to Teladoc Health (TDOC) Stock for Now?
by Zacks Equity Research
Teladoc Health's (TDOC) cash-generating abilities are boosted by the growing number of visits and memberships.
InnovAge Holding Corp. (INNV) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Medical Services Stocks to Buy Amid Industry Challenges
by Urmimala Biswas
The Zacks Medical - Services industry is growing on digital healthcare adoption. EMBC, INNV and OCX are set to gain the most. However, staffing shortages may disrupt the trend.
InnovAge Holding Corp. (INNV) Loses -7.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for InnovAge Holding Corp. (INNV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
InnovAge Holding Corp. (INNV) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of 36.36% and 1.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
InnovAge Holding Corp. (INNV) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -150% and 1.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Agilon (AGL) delivered earnings and revenue surprises of -40% and 6.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Doximity (DOCS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Doximity (DOCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: InnovAge Holding Corp. (INNV) Q1 Earnings Expected to Decline
by Zacks Equity Research
InnovAge Holding Corp. (INNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights InnovAge Holding, Spirit AeroSystems Holdings, Tandem Diabetes Care and HCI Group
by Zacks Equity Research
InnovAge Holding, Spirit AeroSystems Holdings, Tandem Diabetes Care and HCI Group have been highlighted in this Screen of The Week article.
4 Toxic Stocks That May Risk Your Peace and Prosperity
by Rimmi Singhi
Stocks like INVV, SPR, TNDM and HCI could prove hazardous for your portfolio. So, it's best to dump these toxic stocks, especially amid the prevailing market mayhem.
InnovAge Holding Corp. (INNV) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -200% and 0.74%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for InnovAge (INNV) Stock Options
by Zacks Equity Research
Investors need to pay close attention to InnovAge (INNV) stock based on the movements in the options market lately.